Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
Ontology highlight
ABSTRACT: This is a Phase 1 open-label, dose-escalation trial using "3+3" design, evaluating MM-151 co-administration with MM-121, MM-141, and trametinib at varying dose levels.
DISEASE(S): Squamous Cell Carcinoma Of Head And Neck,Squamous Cell Carcinoma Of The Head And Neck,Non-small Cell Lung Cancer,Colorectal Cancer,Cancer
PROVIDER: 2197256 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA